How Ozempic helps manage fatty liver disease Ozempic's active ingredient is semaglutide, a GLP-1 receptor agonist that manages blood sugar by increasing insulin levels, slowing gastric emptying ...

Tufts University scientists are aiming to revolutionize the future of weight loss drugs by engineering a new compound that ...

GLP-1 agonist medications such as Ozempic and Wegovy are in high demand ... 53 percent lower risk of liver cancer, 48 percent lower risk of ovarian cancer, 46 percent lower risk of colorectal ...

Weight-loss drugs like Ozempic and Wegovy are used by more than 15 million adults in the U.S., or 4.5% of the population.

GLP-1 medications offer promising benefits for obesity and diabetes patients, with studies showing reduced heart attack risk ...

This hormone prompts the liver to release glucose (sugar ... What to know about Ozempic and kidney disease The relationship between Ozempic and kidney disease is unclear. At first, kidney ...

Q. I’ve been on Ozempic for several months now. My blood sugar in the morning is around 103, down from about 180 before. I’ve lost 30 pounds. The weight off my knees has been great. Initially, I had ...

Mazdutide, used in the treatment of obesity and metabolic diseases, could become the first domestically-developed dual-target obesity drug to reach the market.

The Wall Street Journal reports on the expected FDA approval of lenacapavir and what it might mean for Gilead's future in the market. Other coverage of science and research-related news is on a ...